Veru - VERU Operating profit EBITDA
Veru Inc. is facing earnings volatility due to a strategic shift toward oncology and regulatory pauses. Revenues are based on the sale of women's health products and the development of cancer therapies. Quarterly EBITDA captures these fluctuations, with the metric currently standing at 0.00. A fully staffed team of specialized experts and scientists is expected to ensure stable growth of indicators in the future.
Veru (VERU) - metric breakdowns and financial figures
- current quotes and average value forecast:
- issuer market value details:
- book value of equity indicators:
- debt level and financial liquidity data:
- earnings and market ratios statistics:
VERU - Net Profit|Company Profit Forecast Veru Inc.|VERU - Price to Earnings Ratio|Price to Future Earnings Ratio verupharma.com|VERU - PEG Multiple|Enterprise Value to EBITDA Ratio Veru|VERU - Operating profit before deduction of amortization|Net earnings per share for the last four quarters Veru|VERU - Net earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months verupharma.com|VERU - Earnings growth in current year|Expected net earnings per share growth next year Veru Inc.
Analysis of all company metrics:Veru Corporation
This indicator calculates operating cash flow before interest and taxes, eliminating the time gap between quarterly reports to assess the business's actual ability to generate cash. Amid intense competition with pharma behemoths, the organization's overall EBITDA demonstrates the financial resilience of Veru Inc. (VERU) in the face of high oncology drug development risks and the struggle for investment capital.
Competitor analysis for Veru Inc.
ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Operating profit before deduction of amortization PSNL (Personalis, Inc.)|Profit before payment of interest, taxes and amortization ERAS (erasca.com)|Operating profit EBITDA DCTH (Delcath Systems)|Y-mAbs Therapeutics Inc (YMAB) - Profit before interest, taxes and amortization|AURA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CADL (Candel Therapeutics)|ARAY (Accuray Incorporated) - Operating profit before deduction of amortization|SELLAS Life Sciences Group (SLS) - Operating profit EBITDA|Operating profit before deduction of amortization ACTU|CTOR: Income before deduction of interest, taxes and amortization|Operating profit EBITDA HURA|Operating income before deduction of amortization Protara Tx|Profit before payment of interest, taxes and amortization Fate Therapeutics, Inc. FATE|WHWK: Operating profit before amortization|TScan - Operating profit EBITDA|Champions Oncology (CSBR) - Operating profit before deduction of amortization|XBIT (xbiotech.com) - Operating profit before deduction of amortization|CVM - Operating income before deduction of amortization|Operating profit before deduction of amortization OSTX|Profit before payment of interest, taxes and amortization RADX|Operating profit EBITDA ARTV|ANL - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Tempest Tx TPST|Income before deduction of interest, taxes and amortization XLO|RENB: Operating profit before deduction of amortization|MURA - Operating profit EBITDA|KAPA: Operating profit EBITDA|Operating profit before deduction of amortization OnKure Therapeutics|GDTC (CytoMed Therapeutics Ltd) - Operating profit EBITDA|Operating profit EBITDA Curis Corp|Profit before payment of interest, taxes and amortization Apollomics, Inc. (APLM)|tharimmune.com - Operating profit before amortization|Operating profit EBITDA ADVB (Advanced Biomed)|GNPX - Operating profit before deduction of amortization|Calidi Bio - Operating profit EBITDA|Profit before interest, taxes and amortization sunshinebiopharma.com|xeneticbio.com (XBIO) - Profit before payment of interest, taxes and amortization|salariuspharma.com - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization PPBT|AONC: Income before deduction of interest, taxes and amortization|Operating profit EBITDA BGNE|Operating profit before deduction of amortization Checkpoint Therapeutics Inc CKPT|Elevation Oncology - Operating profit before deduction of amortization|Operating profit EBITDA iCAD Inc. ICAD|IKNA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NTBL (Notable Labs Ltd)|VIRX: Operating profit EBITDA|Profit before interest, taxes and amortization MorphoSys Corporation (MOR)|Operating profit before deduction of amortization NAYA|Profit before payment of interest, taxes and amortization AAPGV
